Plain-English translation of NCT06279000 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing whether , a medication that reduces inflammation in the body, can help protect your heart when you're having major surgery. People who are at higher risk for heart complications are being invited to participate. The researchers want to see if taking this medication around the time of surgery reduces heart injury and other serious heart events.
Heart damage during and after major surgery is a real concern, especially for people who already have heart disease or other heart risk factors. Researchers believe that reducing inflammation with this medication might help prevent or minimize that damage, but they need to test whether it actually works.
You likely qualify if…
You likely don't qualify if…
If you join this study, you'll receive either the medication or a placebo (a pill with no active ingredient) starting the evening before your scheduled surgery. You'll take pills in a specific pattern through the third day after surgery. Researchers will check your heart using blood tests daily for the first few days after surgery, and you'll have follow-up visits to monitor for any heart problems. The study team will track your recovery and watch for any serious heart events for up to one year after your surgery.
AI-generated summary from trial data · Jul 7, 2026 · Not medical advice
Switzerland